ID   HepG2-CYP2E1
AC   CVCL_A2HH
DR   cancercelllines; CVCL_A2HH
DR   Wikidata; Q105507643
RX   PubMed=14669323;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; 7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Transfected with: HGNC; 2631; CYP2E1.
CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 05-10-23; Version: 5
//
RX   PubMed=14669323; DOI=10.3748/wjg.v9.i12.2732;
RA   Zhuge J., Luo Y., Yu Y.-N.;
RT   "Heterologous expression of human cytochrome P450 2E1 in HepG2 cell
RT   line.";
RL   World J. Gastroenterol. 9:2732-2736(2003).
//